Moderna, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA
MRNA chart
What traders are saying about $MRNA
Latest postsModerna, Inc. news
- Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%
WBUR ·
- Scancell cancer vaccine strategy backed by Moderna and Merck trial results
proactiveinvestors.com ·
- Broadcom upgraded, HubSpot downgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Moderna shares slip as William Blair cuts rating on valuation after rally
Yahoo Finance ·
- Moderna’s CEO Gives an Inside Look at the Biotech’s New Era
Yahoo Finance ·
- Moderna’s Billionaire Co-Founder Is Betting on More Improbable Ideas
Bloomberg.com ·
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Broadcom, Conoco Phillips, HubSpot, MercadoLibre, Moderna, Occidental Petroleum, PNC Financial, Trimble, and More
247wallst.com ·
- Moderna shares steady after ESMO data leak crash
EMJ ·
- Oracle, IBM and Intel Have Opted Out of OKX-ICE Stock Tokens, Venue’s Own Notice Shows
unchainedcrypto.com ·
- Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
ABC News - Breaking News, Latest News and Videos ·
- Moderna (MRNA) Gets Phase 3 Melanoma Vaccine Validation At ESMO And NEJM
Yahoo Finance ·
- Merck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline Catalysts
marketbeat.com ·
Moderna, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.94B | $3.24B | $6.85B | $19.26B |
| Net income | -$2.82B | -$3.56B | -$4.71B | $8.36B |
| Diluted EPS | $-7.26 | $-9.28 | $-12.33 | $20.12 |
| Total assets (year end) | $12.34B | $14.14B | $18.43B | $25.86B |
| Cash and equivalents (year end) | $2.60B | $1.93B | $2.91B | $3.21B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Moderna, Inc.
- Ticker
- MRNA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1682852
- Former names
- Moderna Therapeutics, Inc.
Frequently asked questions
What exchange is Moderna, Inc. listed on?
Moderna, Inc. trades on the Nasdaq under the ticker symbol MRNA.
What industry is Moderna, Inc. in?
Moderna, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Moderna, Inc. headquartered?
Moderna, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Moderna, Inc.'s fiscal year end?
Moderna, Inc.'s fiscal year ends on December 31.
How much revenue did Moderna, Inc. report?
Moderna, Inc. reported $1.94B in revenue for calendar year 2025, according to its SEC filings.